and recommendation
StemCells, Inc. (STEM)
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimers disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.
- January 5, 2017 - 8:36am | Research Notes
- January 4, 2017 - 9:48am | Research Notes
- January 3, 2017 - 10:57am | Research Notes
- December 14, 2016 - 9:16am | Research Notes
- November 2, 2016 - 8:46pm | Earnings, Earnings Q3
- November 1, 2016 - 9:30am | Research Notes
- November 1, 2016 - 9:19am | Research Notes
- October 27, 2016 - 10:38am | Research Notes, Financings
- September 8, 2016 - 8:58am | Research Notes
- September 6, 2016 - 10:29am | Research Notes
- September 6, 2016 - 8:09am | Research Notes
- August 26, 2016 - 8:26am | Research Notes
- August 16, 2016 - 11:05am | Research Notes
- August 4, 2016 - 10:50pm | Earnings, Earnings Q2
- August 3, 2016 - 10:41am | Research Notes
- July 26, 2016 - 6:35am | Research Notes
- July 21, 2016 - 9:35am | Research Notes
- June 27, 2016 - 7:12am | Research Notes
- June 27, 2016 - 6:51am | Research Notes
- June 24, 2016 - 12:48pm | Research Notes